Intelligent Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . Intelligent Bio Solutions
INBS Stock  USD 2.12  0.02  0.95%   
Intelligent Bio financial statements provide useful quarterly and yearly information to potential Intelligent Bio Solutions investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Intelligent Bio financial statements helps investors assess Intelligent Bio's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Intelligent Bio's valuation are summarized below:
Gross Profit
326.7 K
Market Capitalization
6.1 M
Enterprise Value Revenue
4.2747
Revenue
3.1 M
Earnings Share
(2.30)
There are over one hundred nineteen available fundamental trends for Intelligent Bio Solutions, which can be analyzed over time and compared to other ratios. All traders should confirm Intelligent Bio's regular fundamentals against the performance from 2010 to 2025 and make sure the trends continue to evolve in the right direction. Market Cap is likely to drop to about 6.4 M in 2025. Enterprise Value is likely to drop to about 433.5 K in 2025

Intelligent Bio Total Revenue

3.76 Million

Check Intelligent Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Intelligent Bio's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.4 M, Interest Expense of 142.9 K or Selling General Administrative of 11.2 M, as well as many indicators such as Price To Sales Ratio of 2.05, Dividend Yield of 0.0 or PTB Ratio of 0.66. Intelligent financial statements analysis is a perfect complement when working with Intelligent Bio Valuation or Volatility modules.
  
Check out the analysis of Intelligent Bio Correlation against competitors.

Intelligent Bio Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets8.9 M15.8 M5.9 M
Slightly volatile
Short and Long Term Debt Total745.1 K784.3 K2.9 M
Slightly volatile
Other Current Liabilities1.2 M1.1 M1.9 M
Slightly volatile
Total Current Liabilities4.6 M4.9 M5.9 M
Slightly volatile
Accounts Payable792.1 K692.7 K580 K
Slightly volatile
Cash4.1 M7.2 M2.6 M
Slightly volatile
Cash And Short Term Investments4.1 M7.2 M2.6 M
Slightly volatile
Liabilities And Stockholders Equity8.9 M15.8 M5.9 M
Slightly volatile
Non Current Liabilities Total123.9 K130.4 K3.1 M
Slightly volatile
Other Current Assets586.1 K545.4 K566.4 K
Very volatile
Total Liabilities5.1 M5 M6.3 M
Slightly volatile
Total Current Assets6.5 M9.8 M4.2 M
Slightly volatile
Short Term Debt910.5 K958.5 K2.8 M
Slightly volatile
Common Stock29.5 K31.1 K325.6 K
Pretty Stable
Net Receivables1.2 M1.1 M638.7 K
Slightly volatile
Common Stock Shares Outstanding3.5 M3.7 M2 M
Slightly volatile
Non Current Assets Total3.5 M6 M2.8 M
Slightly volatile
Non Currrent Assets Other1 M983.5 K1.6 M
Slightly volatile
Short and Long Term Debt440.6 K463.8 K3.4 M
Slightly volatile
Capital Stock29.5 K31.1 K10.8 M
Slightly volatile
Other Liabilities21.3 K22.4 K2.3 M
Slightly volatile
Current Deferred Revenue2.7 M2.9 M2.3 M
Slightly volatile
Deferred Long Term Liabilities403.2 K453.6 K494.6 K
Slightly volatile
Property Plant Equipment895.4 K1.4 M593 K
Slightly volatile
Long Term Debt322.3 K362.6 K395.3 K
Slightly volatile
Short Term Investments94.6 K106.4 K116 K
Slightly volatile
Intangible Assets3.9 M3.9 M5 M
Slightly volatile

Intelligent Bio Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization1.4 M1.4 M727.1 K
Slightly volatile
Interest Expense142.9 K150.4 K408.7 K
Slightly volatile
Selling General Administrative11.2 M10.6 M4.2 M
Slightly volatile
Other Operating Expenses8.3 M15.4 M6.8 M
Slightly volatile
Research Development1.9 M1.5 M2.4 M
Pretty Stable
Total Operating Expenses7.9 M13.5 M6.5 M
Slightly volatile
Interest Income102.4 K97.5 K20.3 K
Slightly volatile
Minority Interest27.3 K30.8 K45.3 K
Slightly volatile

Intelligent Bio Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow1.7 M1.8 M1.7 M
Slightly volatile
Total Cash From Financing Activities17.6 M16.7 M7.7 M
Slightly volatile
End Period Cash Flow4.7 M7.2 M2.8 M
Slightly volatile
Change To Netincome1.6 M2.5 M1.8 M
Very volatile
Depreciation1.1 M1.4 M1 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio2.052.156.2 K
Slightly volatile
Days Sales Outstanding125132114
Slightly volatile
Average Payables719.4 K809.4 K882.4 K
Slightly volatile
Stock Based Compensation To Revenue0.08090.08523.034
Slightly volatile
Capex To Depreciation0.390.210.4734
Slightly volatile
EV To Sales0.140.156.3 K
Slightly volatile
Inventory Turnover1.251.951.1068
Slightly volatile
Days Of Inventory On Hand304194354
Slightly volatile
Payables Turnover1.432.521.0536
Slightly volatile
Sales General And Administrative To Revenue2.052.158.7721
Slightly volatile
Research And Ddevelopement To Revenue0.590.622.2422
Slightly volatile
Capex To Revenue0.07770.08180.341
Slightly volatile
Cash Per Share2.451.781.8272
Slightly volatile
Days Payables Outstanding142150408
Slightly volatile
Income Quality0.881.080.8155
Pretty Stable
Intangibles To Total Assets0.450.360.4828
Slightly volatile
Current Ratio1.021.410.829
Slightly volatile
Receivables Turnover4.13.666.9317
Slightly volatile
Capex Per Share0.07590.07990.2242
Slightly volatile
Average Receivables2.7 M2.6 M1.1 M
Slightly volatile
Revenue Per Share0.830.880.5551
Slightly volatile
Interest Debt Per Share0.360.373.9353
Slightly volatile
Debt To Assets0.06910.07272.743
Slightly volatile
Operating Cycle308255192
Slightly volatile
Days Of Payables Outstanding142150408
Slightly volatile
Ebt Per Ebit1.311.141.4246
Slightly volatile
Long Term Debt To Capitalization0.140.150.1638
Slightly volatile
Quick Ratio0.981.280.7958
Slightly volatile
Net Income Per E B T1.081.151.0309
Slightly volatile
Cash Ratio0.681.040.5338
Slightly volatile
Cash Conversion Cycle258176117
Slightly volatile
Days Of Inventory Outstanding304194354
Slightly volatile
Days Of Sales Outstanding125132114
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.181.02311.1131
Very volatile
Fixed Asset Turnover1.833.211.3637
Slightly volatile
Debt Ratio0.06910.07272.743
Slightly volatile
Price Sales Ratio2.052.156.2 K
Slightly volatile
Asset Turnover0.10.20.1018
Slightly volatile
Gross Profit Margin0.290.410.2836
Slightly volatile

Intelligent Bio Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap6.4 M6.7 M1.1 B
Slightly volatile
Enterprise Value433.5 K456.3 K1.1 B
Slightly volatile

Intelligent Fundamental Market Drivers

Cash And Short Term Investments6.3 M

Intelligent Upcoming Events

13th of February 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
22nd of August 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
30th of June 2023
Last Financial Announcement
View

About Intelligent Bio Financial Statements

Intelligent Bio shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Intelligent Bio investors may analyze each financial statement separately, they are all interrelated. The changes in Intelligent Bio's assets and liabilities, for example, are also reflected in the revenues and expenses on on Intelligent Bio's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue2.9 M2.7 M
Total Revenue3.6 M3.8 M
Cost Of Revenue1.9 M2 M
Stock Based Compensation To Revenue 0.09  0.08 
Sales General And Administrative To Revenue 2.15  2.05 
Research And Ddevelopement To Revenue 0.62  0.59 
Capex To Revenue 0.08  0.08 
Revenue Per Share 0.88  0.83 
Ebit Per Revenue(2.97)(3.12)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Intelligent Stock Analysis

When running Intelligent Bio's price analysis, check to measure Intelligent Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intelligent Bio is operating at the current time. Most of Intelligent Bio's value examination focuses on studying past and present price action to predict the probability of Intelligent Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intelligent Bio's price. Additionally, you may evaluate how the addition of Intelligent Bio to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY